Dubber Corporation Limited (DUB.AX)
AUD 0.03
(-5.88%)
AUD 0.03
(-5.88%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 38.65 Million | 30.02 Million | 16.31 Million | 20.33 Million | 9.64 Million | 5.61 Million |
| Cost of Revenue | 46.3 Million | 80.9 Million | 78.94 Million | 35.53 Million | 21.86 Million | 12.01 Million |
| Gross Profit | -7.64 Million | -50.87 Million | -62.62 Million | -15.19 Million | -12.21 Million | -6.4 Million |
| Operating Expenses | 16.25 Million | 17.26 Million | 20.49 Million | 18.11 Million | 7.71 Million | 3.25 Million |
| Selling, General and Administrative Expenses | 16.25 Million | 17.26 Million | 20.49 Million | 18.11 Million | 7.71 Million | 3.3 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.59 Million | -23.58 Thousand | 2.53 Million | 2.01 Million | 1.69 Million |
| Cost and Expenses | 62.56 Million | 98.16 Million | 99.44 Million | 53.65 Million | 29.58 Million | 15.27 Million |
| Operating Income | -23.9 Million | -68.13 Million | -83.12 Million | -33.31 Million | -19.93 Million | -9.53 Million |
| Interest Expense | 4.14 Million | 794.78 Thousand | 1.99 Million | 1.46 Million | 148.83 Thousand | 19.08 Thousand |
| Income Tax Expense | -80.61 Thousand | -876.63 Thousand | -827.9 Thousand | -2.09 Million | -1.63 Million | -1.7 Million |
| Earnings before Tax | -40.8 Million | -70.07 Million | -84.93 Million | -33.79 Million | -19.63 Million | -9.64 Million |
| Net Income | -40.72 Million | -69.19 Million | -84.1 Million | -31.69 Million | -18 Million | -9.64 Million |
| Earnings Per Share Basic | -0.09 | -0.23 | -0.28 | -0.13 | -0.09 | -0.06 |
| Earnings Per Share Diluted | -0.09 | -0.23 | -0.28 | -0.13 | -0.09 | -0.06 |
| Weighted Average Shares Outstanding | 465.14 Million | 307.17 Million | 297.99 Million | 239.17 Million | 193.59 Million | 155.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 465.14 Million | 307.17 Million | 297.99 Million | 239.17 Million | 193.59 Million | 155.23 Million |
| Gross Margin | -0.20 | -1.69 | -3.84 | -0.75 | -1.27 | -1.14 |
| EBIT Margin | -0.74 | -1.99 | -4.65 | -1.49 | -1.85 | -1.42 |
| Profit Margin | -1.05 | -2.30 | -5.15 | -1.56 | -1.87 | -1.72 |
| EBITDA | -28.5 Million | -60.79 Million | -75.67 Million | -27.47 Million | -16.47 Million | -7.96 Million |
| Earnings Before Tax Margin | -0.62 | -2.27 | -5.09 | -1.64 | -2.07 | -1.70 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 19.93 Million | 38.65 Million | 18.72 Million | 16.35 Million | 30.02 Million | 13.67 Million |
| Cost of Revenue | 24.17 Million | 54.46 Million | 30.29 Million | 39.42 Million | 80.9 Million | 41.47 Million |
| Gross Profit | -4.23 Million | -15.8 Million | -11.56 Million | -23.07 Million | -50.87 Million | -27.79 Million |
| Operating Expenses | 10.01 Million | 16.25 Million | 6.24 Million | 8.23 Million | 17.26 Million | 9.03 Million |
| Selling, General and Administrative Expenses | 10.01 Million | - | 6.24 Million | 8.23 Million | - | 9.03 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | 1.59 Million | - |
| Cost and Expenses | 34.18 Million | 70.71 Million | 36.53 Million | 47.66 Million | 98.16 Million | 50.5 Million |
| Operating Income | -14.25 Million | -32.05 Million | -17.8 Million | -31.3 Million | -68.13 Million | -36.82 Million |
| Interest Expense | 3.34 Million | 4.14 Million | 800.71 Thousand | 270.52 Thousand | 794.78 Thousand | 524.25 Thousand |
| Income Tax Expense | 333.79 Thousand | -80.61 Thousand | -414.4 Thousand | -961.02 Thousand | -876.63 Thousand | 84.39 Thousand |
| Earnings before Tax | -18.24 Million | -40.8 Million | -22.56 Million | -33.08 Million | -70.07 Million | -36.98 Million |
| Net Income | -18.57 Million | -40.72 Million | -22.14 Million | -32.12 Million | -69.19 Million | -37.06 Million |
| Earnings Per Share Basic | -0.03 | - | -0.04 | -0.06 | - | -0.07 |
| Earnings Per Share Diluted | -0.03 | - | -0.04 | -0.06 | - | -0.07 |
| Weighted Average Shares Outstanding | 687.94 Million | 465.14 Million | 597.64 Million | 504.68 Million | 307.17 Million | 501.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.94 Million | 465.14 Million | 597.64 Million | 504.68 Million | 307.17 Million | 501.18 Million |
| Gross Margin | -0.21 | -0.41 | -0.62 | -1.41 | -1.69 | -2.03 |
| EBIT Margin | -0.51 | - | -0.73 | -1.69 | - | -2.35 |
| Profit Margin | -0.93 | -1.05 | -1.18 | -1.96 | -2.30 | -2.71 |
| EBITDA | -10.22 Million | - | -13.67 Million | -27.61 Million | - | -32.12 Million |
| Earnings Before Tax Margin | -0.72 | -0.83 | -0.95 | -1.91 | -2.27 | -2.69 |
603380
2102
603912
9958
600515
TORNTPHARM